Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

Efficacy and Influencing Factors of Mindfulness-Based Exposure Group Therapy for OCD

Mindfulness-Based Exposure Group Therapy for Obsessive-compulsive Disorder: A Randomized Controlled Trial

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Obessive-Compulsive Disorder (OCD) is frequently treatment-refractory and imposes a substantial burden on affected individuals. Although Exposure and Response Prevention (ERP) is widely regarded as the first-line intervention, its inherently distressing nature contributes to treatment refusal and premature dropout in a subset of patients. The present study aims to develop and validate a novel intervention, Mindfulness-Based Exposure Therapy (MBET). In contrast to existing protocols that incorporate mindfulness as an adjunct to ERP and have yielded mixed or limited benefits, this study seeks a theoretically grounded integration of mindfulness and exposure-based principles. We hypothesize that mindfulness training improves emotion regulation, thereby producing a synergistic effect that enhances patients' capacity to engage in and complete exposure tasks. From a clinical perspective, MBET is intended to offer a more tolerable and acceptable alternative to standard ERP, with the potential to improve treatment adherence and clinical outcomes among patients who experience traditional exposure procedures as excessively distressing.

Who May Be Eligible (Plain English)

Who May Qualify: - Have a primary diagnosis of Obsessive-Compulsive Disorder (OCD) according to DSM-5 criteria - Are between 16 and 55 years of age (inclusive) - Have a Yale-Brown Obsessive Compulsive Scale (Y-BOCS) total score ≥ 16 - Have an education level of junior high school or above - Are medication-free or have been stabilized on psychotropic medication for at least 8 weeks - Have sufficient visual and auditory capabilities to complete study assessments - Are willing to participate and provide written willing to sign a consent form Who Should NOT Join This Trial: - Meet DSM-5 criteria for any other psychiatric disorder besides OCD - Have severe OCD symptoms that prevent completion of assessments - Exhibit active suicidal ideation or high suicide risk - Have a serious somatic disease, central nervous system disease, or substance abuse history - Are pregnant, breastfeeding, or planning pregnancy - Have metal implants contraindicated for MRI (e.g., pacemakers, intracranial clips, metal dentures, arterial stents, joint fixations) Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Have a primary diagnosis of Obsessive-Compulsive Disorder (OCD) according to DSM-5 criteria * Are between 16 and 55 years of age (inclusive) * Have a Yale-Brown Obsessive Compulsive Scale (Y-BOCS) total score ≥ 16 * Have an education level of junior high school or above * Are medication-free or have been stabilized on psychotropic medication for at least 8 weeks * Have sufficient visual and auditory capabilities to complete study assessments * Are willing to participate and provide written informed consent Exclusion Criteria: * Meet DSM-5 criteria for any other psychiatric disorder besides OCD * Have severe OCD symptoms that prevent completion of assessments * Exhibit active suicidal ideation or high suicide risk * Have a serious somatic disease, central nervous system disease, or substance abuse history * Are pregnant, breastfeeding, or planning pregnancy * Have metal implants contraindicated for MRI (e.g., pacemakers, intracranial clips, metal dentures, arterial stents, joint fixations)

Treatments Being Tested

BEHAVIORAL

mindfulness based exposure therapy

Mindfulness-Based Exposure Therapy (MBET) is a structured, 10-week group psychological intervention specifically designed for individuals with Obsessive-Compulsive Disorder (OCD). The program is delivered in weekly sessions, with each session lasting 3 hours. To ensure optimal group dynamics and personalized attention, each group consists of 6 to 8 patients and is facilitated by 1 to 2 trained therapists.To reinforce the skills acquired during the group meetings, participants are assigned daily homework at the end of each session, which requires 30 to 60 minutes of independent practice per day. At its core, the treatment process features a deep integration of mindfulness and Exposure and Response Prevention (ERP). Rather than treating these as separate components, MBET seamlessly embeds the core philosophies and practices of mindfulness directly into the ERP exercises, allowing patients to apply mindful awareness and acceptance while actively confronting their obsessional triggers.

OTHER

Treatment as Usual (TAU)

treatment as usual with stable medication

Locations (1)

Shanghai mental health center
Shanghai, Shanghai Municipality, China